Brief: Fusion Pharmaceuticals Files For Resale Of Up To 17.65 Mln Common Shares By Selling Shareholders
16/03/2023 22:40
March 16 (Reuters) - Fusion Pharmaceuticals Inc
FUSN.O :
* FUSION PHARMACEUTICALS INC FILES FOR RESALE OF UP TO 17.65
MILLION COMMON SHARES BY THE SELLING SHAREHOLDERS - SEC FILING
Further company coverage: FUSN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fusion Pharmaceuticals
See all newsBrief: Acquisition Of Fusion Pharmaceuticals Completed
Brief: Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Fusion Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary